NCT05789901Recruiting
The MARVIN Chatbots to Provide Information for Different Health Conditions
A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots
Source: ClinicalTrials.gov · Last updated 6 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 14 Mar 2023
- Start date
- 1 Mar 2024
- Primary completion date
- 31 Dec 2033
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Diseases
- HIV, Childhood cancers
- NCT number
- NCT05789901
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 1 Mar 2024 to the primary completion date, 31 Dec 2033
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- not meeting the inclusion criteria
- any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)
Who the study is looking for
- being 14 years or older;
- being fluent in English and/or French;
- being able to understand the requirements of study participation and provide informed consent during the duration of the study;
- having access to a smartphone, tablet, or computer at home/at workplace;
- having access to an internet connection at home or data plan on their device.
- accept to use a Facebook Messenger-based Chatbot;
- accept to use or create a personal Facebook account;
- accept Facebook's privacy and data security policies.
Age in the registry: 14 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier de l'Universite de Montreal (CHUM) Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
| McGill University Health Centre (MUHC) Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.